Downregulation of STAT1 has been shown to inhibit inflammation in respiratory diseases, e.g., chronic obstructive pulmonary disease (40), and potentially to treat severe COVID-19 disease (41). The gene discussed is STAT1; the disease is respiratory system disorder.